Cite
HARVARD Citation
Kanada, S. et al. (n.d.). Pharmacokinetics, pharmacodynamics, safety and tolerability of 4 weeks' treatment with empagliflozin in Japanese patients with type 2 diabetes mellitus. Journal of diabetes investigation. 4 (6), pp. 613-617. [Online].